Compare HCA Health Inc (HCA) vs Honest Company Inc (HNST) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
HCA Health Inc vs Honest Company Inc — how do they compare? HCA Health Inc trades at $446.94 (market cap $96.35B), while Honest Company Inc trades at $4.99 (market cap $533.20M). The key difference: HCA Health Inc is far larger — about 180.7× Honest Company Inc's market cap, and HCA Health Inc pays a 0.7% dividend while Honest Company Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold HCA Health Inc for 76 Days and Honest Company Inc for 39 Days on average.
| HCA | HNST | |
|---|---|---|
Market Cap | $96.35B | $533.20M |
Volume | 1,079,453 | 1,990,155 |
Sector | Health | Consumer Staples |
52-Week High | $545.13 | $5.95 |
52-Week Low | $361.32 | $2.10 |
Typical Hold Time | 76 Days | 39 Days |
Enterprise Value | $146.88B | $436.81M |
Dividend Yield | 0.7% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
HCA Healthcare (HCA) trades at $439.17, up 1.61% today, with a bullish technical signal and strong fundamental performance. Revenue grew to $75.6 billion in 2025, with net income reaching $6.78 billion, and the company has beaten EPS estimates for three consecutive quarters. Recent news includes an upcoming Q3 2026 earnings call and the completion of the College of Health Care Professions acquisition, highlighting operational expansion.
The outlook remains positive with a consensus price target of $461.12, though risks include ongoing legal investigations and high debt levels. Earnings growth and cost controls support upside potential, but investors should monitor regulatory developments and payer-mix pressures that could impact margins.
HNST trades at $4.93, down 1.99% today, with a bearish technical outlook despite recent earnings beat. The company shows mixed fundamentals with negative net income margin (-3.56%) and ROE (-6.87%), though Q2 2026 EPS of $0.04 exceeded expectations. Revenue declined to $371M in 2025, but operating cash flow improved to $15.1M. Analyst consensus is mixed with 30% buy ratings and $5.30 price target.
The stock faces headwinds from profitability challenges and competitive pressures, though strategic exits show early signs of margin improvement. Upside potential exists if the company sustains recent operational improvements, but investors should weigh the high P/E ratio of 48.83 against ongoing net losses.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About HCA Health Inc
HCA Healthcare is a Nashville-based healthcare provider organization operating the largest collection of acute-care hospitals in the U.S. As of December 2021, the firm owned and operated 182 hospitals, 125 freestanding outpatient surgery centers, and a broad network of physician offices, urgent care clinics, and freestanding emergency rooms across nearly 20 states and a small foothold in England.
Read more on HCA →About Honest Company Inc
The Honest Co Inc is a consumer products company. It offers eco-friendly diapers and a natural line of bath, skincare, home cleaning, and organic nutritional supplement products and other products.
Read more on HNST →
